Table 2.
Comparison of Cellular Localization of LOXL-2 Immunoexpression with Clinicopathological Parameters
| Clinico- Pathological Parameters | No. of cases | A -17 |
B -2 |
C -33 |
D -38 |
P-value | |
|---|---|---|---|---|---|---|---|
| Tumor stage (T) | Total | 90 | 0.682 | ||||
| T1 | 21 | 7 | 0 | 5 | 9 | ||
| T2 | 33 | 4 | 1 | 14 | 14 | ||
| T3 | 8 | 2 | 0 | 2 | 4 | ||
| T4a | 28 | 4 | 1 | 12 | 11 | ||
| Nodal stage (N0) | Total | 90 | 0.038* | ||||
| N0 | 31 | 6 | 2 | 16 | 7 | ||
| N1 | 42 | 4 | 0 | 15 | 23 | ||
| N2a | 4 | 2 | 0 | 0 | 2 | ||
| N2b | 10 | 3 | 0 | 2 | 5 | ||
| N2c | 3 | 2 | 0 | 0 | 1 | ||
| Clinical Stage (TNM) | Total | 90 | 0.511 | ||||
| I | 12 | 3 | 0 | 5 | 4 | ||
| II | 13 | 3 | 1 | 7 | 2 | ||
| III | 28 | 4 | 0 | 9 | 15 | ||
| IVa | 37 | 7 | 1 | 12 | 17 | ||
| Histological Grade | Total | 90 | 0.518 | ||||
| I | 38 | 8 | 1 | 14 | 15 | ||
| II | 38 | 4 | 1 | 14 | 19 | ||
| III | 14 | 5 | 0 | 5 | 4 | ||
| Areca nut Habit | Total | 90 | 0.097 | ||||
| Present | 63 | 15 | 2 | 24 | 22 | ||
| Absent | 27 | 2 | 0 | 9 | 16 | ||
*, indicates significant result